Elbit Systems Wins $212M Night Vision Order, But Valuation Overhang Persists

What happened

Elbit Systems' U.S. subsidiary received a $212 million delivery order from the U.S. Army for Enhanced Night Vision Goggle-Binocular systems, adding to the company's record backlog of $25.2 billion. The order underscores continued demand for Elbit's advanced electro-optical systems, a core part of its defense portfolio. However, this incremental win does little to address the fundamental valuation concern: ESLT trades at ~73x trailing EPS, far above defense peers. The DeepValue master report rates ESLT a POTENTIAL SELL, citing that the current price already prices in sustained high-teens growth while ESG and political risks in Europe threaten future contract wins. Until backlog conversion accelerates or the multiple compresses to a more reasonable level, the risk/reward remains unfavorable for new capital.

Implication

While the $212 million award reinforces Elbit's operational momentum and U.S. Army relationship, it does not shift the investment thesis. The stock's 142% run over the past year has priced in aggressive earnings growth, leaving little margin of safety. Investors should focus on upcoming quarterly results for signs of margin expansion and any resolution of ESG-driven procurement issues in Europe. Without a meaningful derating or a clear catalyst for sustained high-teens EPS growth, the risk of multiple compression outweighs potential upside.

Thesis delta

This contract win is consistent with the existing narrative of robust demand and backlog growth, but does not alter the core thesis that ESLT's valuation is stretched. The POTENTIAL SELL rating and bearish bias remain unchanged, as the order is an incremental positive already discounted by the market.